Narcotic Drugs Amendment (Medicinal Cannabis) 2021

# Narcotic Drugs Amendment (Medicinal Cannabis) 2021 ## What it does This law expands Australia's medicinal cannabis rules to allow the manufacture and supply of cannabis-based drugs, not just cultivation and production. Previously, the system only covered growing cannabis plants and making raw cannabis products for medical research—now it creates pathways to turn those into finished medicines that can be distributed to patients. ## Why it matters It removes a legal bottleneck that was preventing medicinal cannabis from reaching patients who might benefit from it. Instead of stopping at the production stage, the law now lets licensed manufacturers create regulated cannabis drugs, similar to how other pharmaceuticals are made and supplied. ## Key details - **What counts as a "cannabis drug"**: The law defines this broadly—it includes raw cannabis, cannabis resin, extracts, tinctures, and any other drug made from the cannabis plant. - **Who can do what**: Growers and producers can cultivate cannabis for medicinal or scientific purposes; manufacturers can produce finished cannabis drugs for permitted supply (meaning through proper legal channels). - **When it starts**: The changes take effect on a date to be announced by the government (within 6 months of Royal Assent at the latest). Existing licences and pending applications get transition rules so nothing falls through the cracks.

🔒 Voting closed — this bill has been decided by parliament